Advertisement

Topics

Mapp Biopharmaceutical Company Profile

16:12 EST 21st November 2017 | BioPortfolio

Mapp Biopharmaceutical was founded in 2003 to develop novel pharmaceuticals for the prevention and treatment of infectious diseases, focusing on unmet needs in global health and biodefense.

As Mapp's products transition to clinical evaluation, licenses are transferred to Mapp's commercialization partner, LeafBio.

ZMapp™
ZMapp is composed of three “humanized” monoclonal antibodies manufactured in plants, specifically Nicotiana. It is an optimized cocktail combining the best components of MB--‐003 (Mapp) and ZMAb (Defyrus/PHAC).

Location

6160 Lusk Blvd.Suite C105
San Diego
California
92121
United States of America

Contact

Phone: 800 372 2176


News Articles [51 Associated News Articles listed on BioPortfolio]

MappBio Announces Contracts with BARDA for ZMapp and Additional Filovirus Medical Countermeasures

San Diego, CA, September 30, 2017 --(PR.com)-- Mapp Biopharmaceutical, Inc., announced today that it has been awarded a Project BioShield contract (HHSO100201700017C) of approximately $46 million by ...

US steps up Ebola response

With gill a total of $170m to MSD, Janssen, Mapp and Regeneron

Policy conditions make or break leaders in biopharmaceutical innovation: Preliminary results from the 2017 BCI Survey

In a world of global investment flows, securing a larger portion of the $150 billion invested per year by the research-based biopharmaceutical industry is anyone’s game. The 2017 results...

‘Lead from where you stand:’ establishing women physician leaders

Women in medicine need to amplify one another, find their “posse,” request coaches and sponsors and craft their own legacy statements, according to an expert speaking during an AMA webinar in hono...

'Lead from where you stand:' Establishing women physician leaders

Women in medicine need to amplify one another, find their “posse,” request coaches and sponsors and craft their own legacy statements, according to an expert speaking during an AMA webinar in hono...

Biopharmaceutical CMO CRO Market to Value $37. ...

The global biopharmaceutical CMO & CRO (contract manufacturing & research) market is expected to reach USD 37.8 billionby 2025, according to this new report. Read more...

How biopharmaceutical collaboration is driving a new era of medicine

Biopharmaceutical innovation, coupled with technological advancements, has brought a new era of medicine transforming how we research and develop new medicines to benefit patients.

PfizerVoice: Biopharmaceutical Industry Creates Economic Opportunity for Americans

The biopharmaceutical industry in America not only contributes to the better health of people all over the world, it also generates economic value for local communities in states all across our countr...

Drugs and Medications [0 Results]

None

PubMed Articles [80 Associated PubMed Articles listed on BioPortfolio]

Exploring the potential of Saccharomyces cerevisiae for biopharmaceutical protein production.

Production of recombinant proteins by yeast plays a vital role in the biopharmaceutical industry. It is therefore desirable to develop yeast platform strains for over-production of various biopharmace...

Evaluating ultraviolet sensitivity of adventitious agents in biopharmaceutical manufacturing.

Incidents of contamination in biopharmaceutical production have highlighted the need to apply alternative or supplementary disinfection techniques. Ultraviolet (UV) irradiation is a well-established m...

Characterization of systems with amino-acids and oligosaccharides as modifiers of biopharmaceutical properties of furosemide.

Furosemide is the most commonly prescribed diuretic drug in spite of its suboptimal biopharmaceutical properties. In this work, the addition of different amino-acids was studied with the aim of select...

Purification of monoclonal antibodies entirely in flow-through mode.

A depth filter is widely used in biopharmaceutical manufacturing process. In this study, we found that buffer exchange to reduce conductivity dramatically improved the removal of impurities in depth f...

Erratum.

Clinical Trials [8 Associated Clinical Trials listed on BioPortfolio]

Trans-MAPP Symptom Patterns Study (SPS)

This study is the second phase of the MAPP Network and is designed to conduct a prospective, observational study of men and women with UCPPS, referred to as the Symptom Patterns Study (SPS...

Trans-MAPP II Study of Urologic Chronic Pelvin Pain

The Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network has been established by the National Institute of Diabetes and Digestive and Kidney Diseases (NID...

Phase III Clinical Study of Efficacy and Safety of Vaccae™ to Prevent Tuberculosis

Mycobacterium Vaccae for Injection (Trade Name "Vaccae") is a kind of bio-products developed by Anhui Zhifei Longcom Biopharmaceutical Co.,Ltd.,and got "The New Drug Certificate "in 1999...

A Positron Emission Tomography (PET) Imaging Study to Investigate the Biodistribution and Clearance of an Albumin Binding Domain Antibody (AlbudAb) GSK3128349 in Healthy Male Subjects

GSK3128349 is a small protein molecule (biopharmaceutical) that binds to albumin in the body, and by itself, has no pharmacological action. A pharmacologically active drug can be attached ...

Juvista in the Non-surgical Improvement of Existing Scars

Renovo, a Biopharmaceutical company involved in the development of drugs to improve the appearance of scars and enhance wound healing, are proposing to carry out research in improving the ...

Companies [856 Associated Companies listed on BioPortfolio]

Mapp Biopharmaceutical

Mapp Biopharmaceutical was founded in 2003 to develop novel pharmaceuticals for the prevention and treatment of infectious diseases, focusing on unmet needs in global health and biodefense. As Mapp'...

Barrier Animal Healthcare

For far too long the control of Ragwort has been haphazard, unreliable and costly, that is until now. Barrier H is an innovation in Ragwort control, destroying this deadly weed in record time, right t...

Bavarian Nordic Research Institute A/S

Bavarian Nordic is a commercially viable international biopharmaceutical company through:Biopharmaceutical innovations Novel prophylactic and therapeutic approaches Development, production, testing an...

bde BioPharmaceutical Resources

bde BioPharmaceutical Resources is affiliated with a consortium of companies & consultants whose expertise can be utilized to perform a full spectrum of regulatory, scientific & manufacturing function...

Biopartners GmbH

BioPartners is an international biopharmaceutical company specialising in accelerating the global development and commercialisation of high quality recombinant biopharmaceutical products.

More Information about "Mapp Biopharmaceutical" on BioPortfolio

We have published hundreds of Mapp Biopharmaceutical news stories on BioPortfolio along with dozens of Mapp Biopharmaceutical Clinical Trials and PubMed Articles about Mapp Biopharmaceutical for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Mapp Biopharmaceutical Companies in our database. You can also find out about relevant Mapp Biopharmaceutical Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...


Corporate Database Quicklinks



Searches Linking to this Company Record